about
Optimal Use of Vaccines for Control of Influenza A Virus in SwineMeasuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesAnimal models for influenza virus pathogenesis, transmission, and immunologyProtective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infectionPeripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza VirusImmune Responses to Influenza Virus and Its Correlation to Age and Inherited FactorsOseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza VirusesEpidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in MexicoDevelopment of live attenuated influenza vaccines against pandemic influenza strains.Possibility of cross-species/subtype reassortments in influenza A viruses: an analysis of nonstructural protein variations.Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment.Adenoviral vectors as novel vaccines for influenza.Integrative analysis of differentially expressed microRNAs of pulmonary alveolar macrophages from piglets during H1N1 swine influenza A virus infectionSwine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 ExpressionBCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study.Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.Highly Predictive Model for a Protective Immune Response to the A(H1N1)pdm2009 Influenza Strain after Seasonal VaccinationThe priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort studyPigs with Severe Combined Immunodeficiency Are Impaired in Controlling Influenza A Virus Infection.Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion.N-linked glycosylation in the hemagglutinin of influenza A viruses.Pediatric influenza vaccination: understanding the T-cell response.Comparison of immune response by virus infection and vaccination to 2009 pandemic influenza A/H1N1 in childrenCross-reactive humoral responses to influenza and their implications for a universal vaccine.Innate immune response to a H3N2 subtype swine influenza virus in newborn porcine trachea cells, alveolar macrophages, and precision-cut lung slices.Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells.Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals.Competition between influenza A virus subtypes through heterosubtypic immunity modulates re-infection and antibody dynamics in the mallard duckEffect of influenza A infection on maturation and function of neonatal monocyte-derived dendritic cellsThemis2 is not required for B cell development, activation, and antibody responses.The comparative profile of lymphoid cells and the T and B cell spectratype of germ-free piglets infected with viruses SIV, PRRSV or PCV2.Fast vaccine design and development based on correlates of protection (COPs).Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genesActivation mechanisms of natural killer cells during influenza virus infectionVaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionHeterosubtypic immunity to influenza A virus infections in mallards may explain existence of multiple virus subtypesProtective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus.Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV diseaseRecombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease.Epithelial cells, the "switchboard" of respiratory immune defense responses: effects of air pollutants.
P2860
Q26783503-9B938086-2C35-4E2A-A968-7B6E00E8F341Q26783884-E96415F5-BAE3-4096-A929-A00C6E70072BQ27024582-F4B60845-8E4B-4972-98B5-ABB9FF907EC2Q27324824-02E4BDA0-120C-4E38-B133-6EE758C0807CQ27336918-EE805BCE-CECD-4C22-8243-0BA9597BB692Q28075495-E998A886-DC8B-458C-A8D6-6CC75434FD6CQ28548477-A3561515-706E-486F-B503-FF4C32D313BFQ28729170-2649FE22-CE1C-47AC-917B-4DDEE424DEF1Q30209998-43589E74-138C-4FB5-A0CB-BE12A41B632CQ30354239-3454F624-3743-467C-B4A1-33EDC15BF86CQ30367637-13E50D52-7693-4EF2-B791-F666586DA7B6Q30370445-19F0509C-026B-492D-9EC8-0FC3BDF9B47EQ30371291-CF8F46E2-E668-45C9-982E-97F6159E7F60Q30372625-41F3D5B3-3553-4438-BD61-6DE246EF2420Q30375629-46DA774D-E93E-4FDE-B6BD-34173F194C4BQ30381864-5AB1C4D8-3B56-47CE-A872-D9EE964894AEQ30385393-46E7BE7D-DD2E-40A6-8CAC-0E805B0F715FQ30392073-034F3D92-4E25-40F1-AE07-BC88C9E073F2Q30396591-F9CE0A09-C263-4FB1-94C7-357F5ACA2712Q30413695-3B71A172-653C-480A-8BF5-F8501F01C239Q30420126-201BA6FE-C379-47E0-854A-31A41075EC13Q30421553-9F1460ED-379D-4442-9B23-CE7F992997C4Q30427059-6364B1B8-9C22-441F-AAC0-6FAFE1F4B807Q30427163-E2706DE7-DA64-4B94-B6B6-E96EED78CB46Q33612279-C2DE3537-F7D1-4A78-8E07-8F6AAC1313CBQ33792922-4604450D-35D0-4213-A4EA-ABBEEBF0FB5FQ33809686-0D54E7DB-F62C-4EF9-9158-BF16E61B0581Q33825695-7F77F861-A829-4374-8C0D-50C10EB0BDFDQ33828292-2D971204-C4FD-459B-BB21-69E0F9EAEC75Q33849219-82EF590D-D30D-46C5-9772-D8425757B4DEQ34145808-F59ABDDC-382A-47ED-9D32-9C52F637A252Q34291098-3FA68A5A-22AD-4435-A04D-E7284FE2709BQ34312364-CE040147-A327-4303-B0A0-DDA76319F736Q34540276-8854D7F2-528D-4791-AEDD-258C45E00BFFQ34700649-D57CCACE-DEA4-4478-905E-4CB9190976A4Q34789297-7F429492-87B0-4A13-ABF5-1FA20C36190CQ34964980-05D5BCA7-8AAD-478A-A094-67A0A3C294EFQ35070176-6C3CBC72-5008-4031-A158-3B7D0B565778Q35070505-C814D5E5-84C0-4EC8-94AE-286FB5CF05BFQ35134068-BE12FE0C-F75C-4E90-9CC2-3859588BC1C0
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immune responses to influenza virus infection.
@ast
Immune responses to influenza virus infection.
@en
type
label
Immune responses to influenza virus infection.
@ast
Immune responses to influenza virus infection.
@en
prefLabel
Immune responses to influenza virus infection.
@ast
Immune responses to influenza virus infection.
@en
P2093
P1433
P1476
Immune responses to influenza virus infection.
@en
P2093
G F Rimmelzwaan
J H C M Kreijtz
R A M Fouchier
P356
10.1016/J.VIRUSRES.2011.09.022
P577
2011-09-22T00:00:00Z